Sector leader Eli Lilly is in a buy zone above a pivot at 1,133.95 ahead of second-quarter results, due on Aug. 5. The post Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real